AstraZeneca has announced $50bn of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America and worldwide.…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
